Release Date: 23/07/19 08:43 Summary: June 2019 Quarterly Report Price Sensitive: Yes Download Document 879.44KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%